Five months after three county officials were cleared of federal criminal charges, one of them has been picked to be ...

RBC Capital Markets adjusted its price target for Regeneron Pharmaceuticals (NASDAQ:REGN), reducing it to $1,045 from the previous target of $1,059. Despite the decrease, the firm maintained its ...

The Rensselaer County Legislature is taking decisive action to protect the health and well-being of county residents with a new resolution introduced by recentl ...

The FDA has paused a study of Amgen’s early-stage candidate AMG 513. Elsewhere, Valneva got another approval and a radiopharma developer raised $112 million.

Regeneron's 2025 outlook includes defensive capital allocation, competitive pressure on Eylea, et cetera. Click here to read ...

After 18 months, the City of Rensselaer’s Planning Department recently presented its draft for revitalizing and redeveloping a 227-acre area along the Hudson River. “We have a lot of improvements and ...

NEW YORK, NY / ACCESS Newswire / January 28, 2025 / If you suffered a loss on your Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) investment and want to learn about a potential recovery under the ...

NEW YORK, NY / ACCESS Newswire / January 24, 2025 / If you suffered a loss on your Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) investment and want to learn about a potential recovery under the ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

Commissions do not affect our editors' opinions or evaluations. The best banks in New York offer a good mix of products and services to meet various needs, competitive rates, favorable account ...

With a market cap of $77.3 billion, Regeneron Pharmaceuticals ... edge science to improve patient outcomes. The Tarrytown, New York-based company is expected to unveil its fiscal Q4 earnings ...